Ondansetron in the prevention of postoperative nausea and vomiting in gynaecological surgery
Dirasat. 1997; 24 (1): 30-33
Dans Anglais
| IMEMR
| ID: emr-44393
ABSTRACT
In a double blind randomized study, we compared the prophylactic antiemetic effect of Ondansetron, a 5 HT3 receptor antagonist with that of placebo on postoperative nausea and vomiting in 92 patients undergoing general anaesthesia for gynaecological surgery. The patients received either 4 mg bolus ondansetron or placebo I.V immediately after induction of general anaesthesia. Postoperative nausea and vomiting were assessed for 24 hrs. The incidence of vomiting was 10.86% in the ondansetron group and 34.78% in the placebo group [p < 0.05]. There was no significant difference in the incidence of nausea between the two groups
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Placebo
/
Complications postopératoires
/
Vomissement
/
Gynécologie
/
Antiémétiques
/
Nausée
Type d'étude:
Essai clinique contrôlé
Limites du sujet:
Femelle
/
Humains
langue:
Anglais
Texte intégral:
Dirasat
Année:
1997
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS